Catalysts for Hikma Pharmaceuticals Plc
852 tracked
Oct 18, 2023
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Aug 31, 2023
approval
ALVIMOPAN โ FDA approval
ALVIMOPAN
โ
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE โ FDA approval
Hikma Pharmaceuticals Plc
โ
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE โ FDA approval
Hikma Pharmaceuticals Plc
โ
Jul 17, 2023
approval
MEPERIDINE HYDROCHLORIDE โ FDA approval
Hikma Pharmaceuticals Plc
โ
Jun 6, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Mar 3, 2023
approval
FENTANYL CITRATE โ FDA approval
Effentora
โ
Jan 20, 2023
approval
FENTANYL CITRATE โ FDA approval
Effentora
โ
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Dec 16, 2022
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Oct 12, 2022
approval
VIGABATRIN โ FDA approval
VIGABATRIN
โ
Sep 16, 2022
approval
LOSARTAN POTASSIUM โ FDA approval
LOSARTAN POTASSIUM
โ
Aug 29, 2022
approval
VIGABATRIN โ FDA approval
VIGABATRIN
โ
Jul 13, 2022
approval
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 17, 2022
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jun 15, 2022
approval
EXEMESTANE โ FDA approval
EXEMESTANE
โ
Jun 14, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
May 3, 2022
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Apr 5, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Apr 5, 2022
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Nov 24, 2021
approval
BUPRENORPHINE HYDROCHLORIDE โ FDA approval
BUPRENORPHINE HYDROCHLORIDE
โ
Jul 22, 2021
approval
MORPHINE SULFATE โ FDA approval
Kapanol
โ
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Jun 4, 2021
approval
IRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) โ FDA approval
ALDACTAZIDE
โ
Jun 2, 2021
approval
METHADONE HYDROCHLORIDE โ FDA approval
METHADONE HYDROCHLORIDE
โ
Jun 2, 2021
approval
METHADONE HYDROCHLORIDE โ FDA approval
METHADONE HYDROCHLORIDE
โ